Literature DB >> 15112360

Expression of tumor related gene NAG6 in gastric cancer and restriction fragment length polymorphism analysis.

Xiao-Mei Zhang1, Shou-Rong Sheng, Xiao-Yan Wang, Liang-Hua Bin, Jie-Ru Wang, Gui-Yuan Li.   

Abstract

AIM: NAG6 gene is a novel tumor related gene identified recently. This study was designed to examine the expression of this gene in gastric cancer and corresponding normal tissues, and to investigate its role in the occurrence and development of gastric cancer, also to study if the genetic structure of NAG6 was altered in gastric cancer.
METHODS: Reverse transcription-polymerase chain reaction (RT-PCR), Northern blot analysis and dot hybridization were used to compare the expression level of NAG6 gene in 42 cases of gastric cancer tissues with their corresponding normal tissues of the same patients respectively. In addition, restriction fragment length polymorphism (RFLP) analysis was adopted to study if the genetic structure of NAG6 was altered in gastric carcinomas.
RESULTS: The expression of NAG6 in 57.1% gastric cancer tissues (25/42) was absent by RT-PCR analysis. The down-regulation rate of NAG6 in gastric cancer tissues was significantly higher than that in corresponding normal tissues (P<0.01). However no correlation between the down-regulation of NAG6 and lymph-node and/or distance metastasis was found in this study (P>0.05). Dot hybridization confirmed the results of RT-PCR. Furthermore, the results of EcoRI RFLP analysis of NAG6 gene demonstrated that 3 of 7 cases of gastric cancer showed loss of 5 kb fragment in comparison with their corresponding normal tissues.
CONCLUSION: NAG6 gene is significantly down regulated in gastric cancer. The loss of genetic materials may be the cause of down-regulation of NAG6 expression. This seems to suggest that NAG6 may represent a candidate of putative tumor suppressor gene at 7q31-32 loci associated with gastric carcinoma. The down-regulation of this gene may play a role in occurrence and development of this disease, however it may not be associated with lymph node and/or distance metastasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15112360      PMCID: PMC4622784          DOI: 10.3748/wjg.v10.i9.1361

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Construction of a high-resolution physical map of the approximate 1-Mb region of human chromosome 7q31.1-q31.2 harboring a putative tumor suppressor gene.

Authors:  J C Zenklusen; L A Weintraub; E D Green
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

Review 2.  Tumor genomics vs. tumor genetics: a paradigm shift?

Authors:  S J Meltzer
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

Review 3.  The use of molecular biology in diagnosis and prognosis of gastric cancer.

Authors:  K F Becker; G Keller; H Hoefler
Journal:  Surg Oncol       Date:  2000-07       Impact factor: 3.279

4.  Microsatellite analyses of loci at 7q31.3-q36 reveal a minimum of two common regions of deletion in nasopharyngeal carcinoma.

Authors:  Guolin Tan; Jianyun Xiao; Yongqian Tian; Longnwen Dong; Nin Jiang; Fenfang Zhan; Guiyuan Li
Journal:  Otolaryngol Head Neck Surg       Date:  2002-03       Impact factor: 3.497

5.  Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer.

Authors:  M Koike; S Takeuchi; J Yokota; S Park; Y Hatta; C W Miller; N Tsuruoka; H P Koeffler
Journal:  Genes Chromosomes Cancer       Date:  1997-05       Impact factor: 5.006

6.  [Establishment of partial gene expression map of 7q32 in nasopharyngeal carcinoma and primary culture normal nasopharyngeal epithelial cells].

Authors:  N Jiang; F Zhan; Y Xie; Z Zeng; M Zhou; L Deng; G Li
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  1998-10-10

Review 7.  Cytogenetic, molecular and functional evidence for novel tumor suppressor genes on the long arm of human chromosome 7.

Authors:  J C Zenklusen; C J Conti
Journal:  Mol Carcinog       Date:  1996-03       Impact factor: 4.784

8.  Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D7S486) and q33-34 (D7S498, D7S505).

Authors:  M Koike; T Tasaka; S Spira; N Tsuruoka; H P Koeffler
Journal:  Leuk Res       Date:  1999-03       Impact factor: 3.156

9.  A cDNA located on chromosome 7q32 shows loss of expression in epithelial cell line of nasopharyngeal carcinoma.

Authors:  N Jiang; F Zhan; G Tan; L Deng; M Zhou; L Cao; Y Qiu; Y Xie; G Li
Journal:  Chin Med J (Engl)       Date:  2000-07       Impact factor: 2.628

Review 10.  Gastric cancer: epidemiologic and biological aspects.

Authors:  M Maltoni; A Volpi; O Nanni; P Bajorko; E Belletti; A M Vecci; M Liverani; S Danesi; D Calistri; L Ricotti; D Amadori
Journal:  Forum (Genova)       Date:  1998 Apr-Jun
View more
  3 in total

1.  Genome-wide screening for DNA variants associated with reading and language traits.

Authors:  A Gialluisi; D F Newbury; E G Wilcutt; R K Olson; J C DeFries; W M Brandler; B F Pennington; S D Smith; T S Scerri; N H Simpson; M Luciano; D M Evans; T C Bates; J F Stein; J B Talcott; A P Monaco; S Paracchini; C Francks; S E Fisher
Journal:  Genes Brain Behav       Date:  2014-08-29       Impact factor: 3.449

2.  Establishment of a cone photoreceptor transplantation platform based on a novel cone-GFP reporter mouse line.

Authors:  Sheila Smiley; Philip E Nickerson; Lacrimioara Comanita; Narsis Daftarian; Ahmed El-Sehemy; En Leh Samuel Tsai; Stuart Matan-Lithwick; Keqin Yan; Sherry Thurig; Yacine Touahri; Rajiv Dixit; Tooka Aavani; Yves De Repentingy; Adam Baker; Catherine Tsilfidis; Jeff Biernaskie; Yves Sauvé; Carol Schuurmans; Rashmi Kothary; Alan J Mears; Valerie A Wallace
Journal:  Sci Rep       Date:  2016-03-11       Impact factor: 4.379

3.  An 8‑gene signature predicts the prognosis of cervical cancer following radiotherapy.

Authors:  Fei Xie; Dan Dong; Na Du; Liang Guo; Weihua Ni; Hongyan Yuan; Nannan Zhang; Jiang Jie; Guomu Liu; Guixiang Tai
Journal:  Mol Med Rep       Date:  2019-07-29       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.